Mimi Billing / Sifted:
London-based LabGenius, which makes use of ML to seek out and design antibody therapies to deal with most cancers, raised a £35M Collection B led by Merck’s VC arm, M Ventures — It is robotic platform is utilizing machine studying to create new molecules to deal with most cancers — UK drug discovery startup LabGenius …
[ad_2]
Source link